Cosmo Pharmaceuticals NV
SIX:CMHC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cosmo Pharmaceuticals NV
SIX:CMHC
|
IE |
|
N
|
Netel Holding AB (publ)
LSE:0AAB
|
SE |
|
Acutus Medical Inc
OTC:AFIB
|
US |
|
Doximity Inc
NYSE:DOCS
|
US |
|
K
|
Kinepolis Group NV
SWB:KPSN
|
BE |
|
Citizens Financial Services Inc
NASDAQ:CZFS
|
US |
|
Hellofresh SE
F:HFG
|
DE |
|
Odfjell SE
F:O7F1
|
NO |
|
U
|
Uzin Utz SE
DUS:UZU
|
DE |
|
C
|
Columbus Circle Capital Corp III
NASDAQ:CCCT
|
US |
|
N
|
Netel Holding AB (publ)
F:2CR
|
SE |
|
B
|
Blackbird PLC
F:FBD
|
UK |
|
H
|
Hellofresh SE
SWB:HFG
|
DE |
|
F
|
flatexDEGIRO AG
XMUN:FTK
|
DE |
|
T
|
Texas Roadhouse Inc
F:ROW
|
US |
|
E
|
Eurobank Ergasias Services and Holdings SA
F:EFGA
|
GR |
|
H
|
Helios Towers PLC
F:8HT
|
UK |
|
V
|
Viva Wine Group AB
F:KY1
|
SE |
|
Z
|
Zwack Unicum Likoripari es Kereskedelmi Nyrt
XMUN:ZWC1
|
HU |
Bankruptcy Probability
Cosmo Pharmaceuticals NV's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Cosmo Pharmaceuticals NV Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IE |
|
Cosmo Pharmaceuticals NV
SIX:CMHC
|
812.8m CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
617.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
351.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
346.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
223.8B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
186.1B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
324.7B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
158.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
121.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Cosmo Pharmaceuticals NV's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Cosmo Pharmaceuticals NV has total debt of 3.6m EUR. This includes both short-term (0 EUR) and long-term (3.6m EUR) debt.
You can find a full breakdown on its Balance Sheet.